Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adderall
Pharma
DEA raises production quota on Takeda's Vyvanse and its generics
With a shortage of ADHD drugs persisting, the DEA has raised production limits on Takeda’s Vyvanse and its generic versions by 24%, the agency said.
Kevin Dunleavy
Sep 4, 2024 3:24pm
Teva's Adderall back in stock
May 22, 2024 5:44pm
House Democrats press Teva, Pfizer and Sandoz on drug shortages
Feb 22, 2024 10:44am
Lawmakers launch probe into FDA's drug shortage oversight
Nov 6, 2023 9:32am
Lawmakers push FDA, DEA for update amid Adderall shortage
Oct 13, 2023 9:35am
Studies show advantages for Supernus' Qelbree in kids and adults
Sep 11, 2023 2:11pm
